Ask Warren

DAE HWA Pharm

067080 · KOSDAQ · ₩067080 · 대화제약

₩9,170▼ ₩180 (1.93%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩41B₩37B₩34B₩37B₩36B₩37B₩40B₩36B
Cost of sales₩26B₩24B₩22B₩25B₩24B₩25B₩24B₩23B
Gross profit₩16B₩13B₩12B₩12B₩12B₩12B₩16B₩13B
Operating income₩3.3B₩454M₩699M₩1B₩285M₩1.1B₩3.4B₩1.7B
Net income₩2.2B−₩266M₩2.5B₩338M−₩220M−₩297M₩611M−₩458M
Net income to shareholders₩1.9B−₩246M₩3.2B−₩429M−₩682M−₩414M₩1.6B₩184M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩220B₩222B₩211B₩206B₩202B₩202B₩206B₩216B
Current assets₩67B₩67B₩62B₩64B₩59B₩59B₩62B₩71B
Cash and equivalents₩2.1B₩5.5B₩1.4B₩2.4B₩1.1B₩1.9B₩1.7B₩4.8B
Total liabilities₩135B₩137B₩132B₩133B₩129B₩128B₩130B₩142B
Current liabilities₩121B₩125B₩121B₩120B₩121B₩118B₩118B₩130B
Borrowings₩102B₩101B₩97B₩100B₩98B₩94B₩99B₩108B
Total equity₩86B₩85B₩79B₩74B₩73B₩74B₩76B₩74B
Shareholders' equity₩81B₩80B₩74B₩69B₩69B₩70B₩72B₩70B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩1.7B₩315M₩2.1B−₩1B−₩117M₩4.5B₩1.8B₩2.2B
Free cash flow−₩1.7B₩315M₩2.1B−₩1B−₩117M₩4.5B₩1.8B₩2.2B
Dividends paid₩0₩1.8B₩0₩876M₩0₩1.8B₩0₩876M

Consolidated where available. Amounts in won.

Also known as: DAE HWA Pharm / 대화제약 / 067080 / KRX:067080

Source: KRX statistical information